… status can still tolerate subsequent treatment. Recombinant antitumor and antivirus protein
(Novaferon) is an interferon-like protein that exhibited significant inhibition of cancer cells in …

… injection or recombinant GM-CSF (n = 120) by subcutaneous … in the Phase II clinical trial, a
Phase III clinical trial has been … of anti-tumor activity in the face of a vigorous antiviral immune …

… subsequent studies, the group has developed recombinant … Open label phase II study (NCT02090101)
evaluated the … in the phase III study of Bermekimab versus placebo (each with …

… antinociceptive, antidiabetes, antitumor or antiviral activity: Levemir… A phase II study against
small cell lung cancer will be … protein with recombinant interleukin-2 that has sown promising …

… This review will focus on the anticancer activity of oncolytic viruses … for viral DNA replication
by blocking host cell antiviral … Two other trials involving colorectal cancer patients with liver …

… leucopenia in colorectal cancer patients treated with chemotherapy. … of anticancer, anti-inflammatory,
antioxidant, antiviral and … In addition, a phase II study was conducted to explore the …

… Preclinical studies have also shown the antitumor activity of … In this randomized phase
II study, patients in arm 1 received … of disease after resection of colorectal cancer (CRC) …

… agents technically represent antiviral vaccines and have … 257 NCT01507103, a Phase II
study testing the therapeutic … 259 in patients with colorectal carcinoma, has been terminated …

… this study, and because of promising clinical antitumor … , breast, ovarian and colon cancer.
Safety and modest evidence … sensitivity to clinically effective antiviral agents. This genetic …

… to improve antitumor activity of Newcastle disease virus. … innate antiviral immune responses
generated in these cells upon … of four patients with colorectal cancer, Hodgkin disease and …